Topline data from both Phase 3 trials is expected in the second quarter of 2026, with NDA submission to follow thereafter.

To learn more about the Phase 3 DIAMOND trials, please visit diamondtrial.com.

VX01-DR-201, is a phase 2, multi-center, double-masked, randomized, placebo-controlled study in patients with moderate to ...

Vantage Biosciences, a clinical stage biotechnology company advancing innovative therapies for diabetic eye diseases, today announced that the first patient has been successfully dosed in its Phase 2 ...

The best sleep position depends on comfort and health conditions. Side and back sleeping are generally considered the ...

Attorneys appealed to the Tennessee governor to pause all executions until next year to allow for courts to review a new ...

DIAMOND is the first and only pivotal trial program ever conducted with a topical treatment for diabetic macular edema (DME)Over 800 patients randomized ...

Defending champion Scottie Scheffler is looking to retain the famous green jacket, but faces stiff competition from Rory ...

Learn more about whether Alvotech or Halozyme Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Catholic Health Initiatives-Iowa is arguing that the loss of an unborn child does not equate to the death of a “person” when ...

A man who formerly resided in Creston was charged April 4 with murder in the first degree and child endangerment, stemming from a January incident. Corbin M. Loudermilk, 25, of Atlantic, is being held ...